Simon Pimstone
postdoctoral student
Simon Pimstone is a co-founder of Xenon Pharmaceuticals and has been instrumental in the company's evolution from gene discovery to drug development. His work has contributed to significant advancements in therapies for epilepsy and other neurological disorders.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
62,406
Power
2,791$
Sentiment
7.00
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 7.00 | 0.16% | +0% | 38,005,238 | 62,406 | $1,700,000 | 2,791$ |
| Totals | 1 | 38,005,238 | 62,406 | $1,700,000 | 2,791$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Xenon was co-founded by postdoctoral student Simon Pimstone in 1996.
7